Market Currents
Enzon Pharmaceuticals (ENZN) discloses it has appointed Icahn Capital's George Hebard to a new...
-
Tuesday, February 28, 2012, 5:42 PM ETEnzon Pharmaceuticals (ENZN) discloses it has appointed Icahn Capital's George Hebard to a new board seat. Carl Icahn has long pushed for a management overhaul at Enzon.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
